Profilo
Andrew King worked as a Senior Director of Discovery & Translational Biology at Ardelyx, Inc. He then served as the Chief Scientific Officer at Chinook Therapeutics, Inc. from 2021 to 2023.
Dr. King holds a doctorate degree from Michigan State University and an undergraduate degree from Murdoch University.
Precedenti posizioni note di Andrew King
| Società | Posizione | Fine |
|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 09/08/2023 |
| ARDELYX, INC. | Corporate Officer/Principal | - |
Formazione di Andrew King
| Murdoch University | Undergraduate Degree |
| Michigan State University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ARDELYX, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA. | Health Technology |
- Borsa valori
- Insiders
- Andrew King
